Obesity treatment and device

• US 8,911,393 B2
• Filed: 02/06/2013
• Issued: 12/16/2014
• Est. Priority Date: 06/03/2004
• Status: Active Grant

• Current Assignee: Mayo Foundation For Medical Education And Research (Mayo Clinic)
• Original Assignee: Mayo Foundation For Medical Education And Research (Mayo Clinic)
• Inventors: Levy, Michael J., Camilleri, Michael L., Murray, Joseph A., Sandborn, William J.
• Primary Examiner(s): HAND, MELANIE JO
• Application Number:
  US13/760,785
• Publication Number:
  US 20130184635A1
• Time in Patent Office: 678 Days
• Field of Search: 604 8- 10, 606/108, 623/23.64, 623/23.65, 623/23.67, 623/23.68
• US Class Current: 604/9
• CPC Class Codes: A61B 17/1114 of the digestive tract, e.g. bowels or oesophagus
• CPC Class Codes: A61B 17/12099 characterised by the location of the occluder
• CPC Class Codes: A61B 17/12136 Balloons
• CPC Class Codes: A61B 2017/1139 Side-to-side connections, e.g. shunt or X-connections
• CPC Class Codes: A61F 5/003 inflatable
• CPC Class Codes: A61F 5/0033 with more than one chamber
• CPC Class Codes: A61F 5/0076 preventing normal digestion, e.g. Bariatric or gastric sleeves
• CPC Class Codes: A61F 5/0079 Pyloric or esophageal obstructions
• CPC Class Codes: A61F 5/0083 Reducing the size of the stomach, e.g. gastroplasty surgical interventions A61B17/00

Abstract

A method and apparatus are disclosed for treating obesity includes an artificial fistula created between gastrointestinal organs such as between the stomach and the colon. The method includes selecting an implant comprising a passageway having an internal lumen with an inlet end and an outlet end. The passageway is positioned passing through a first wall of first gastrointestinal organ (for example, passing through the wall of the stomach) and a second wall of a second gastrointestinal organ (for example, passing through the wall of the large intestine) with the inlet end disposed within an interior of the first gastrointestinal organ and with the outlet disposed within an interior of the second gastrointestinal organ.

Claims

1. An apparatus for creating a fistula between a stomach and an intestine of a patient, said apparatus comprising

a flow controller for creating a fistula from said stomach to said intestine of said patient comprising:

a) a flexible passageway having an internal lumen with an inlet end and an outlet end, said passageway sized to extend from said stomach to said intestine with said inlet residing in said stomach and with said outlet residing in said intestine, and having a valve for controlling the flow of contents through the passageway;

b) a first expandable chamber attached to the passageway proximate said inlet and sized to occupy a substantial volume of the antrum; and

c) second expandable chamber attached to the passageway proximate said outlet;

wherein said first and second chambers are adapted to seal against opposing tissue of at least one of said stomach and said intestine upon expansion of said chambers; and

d) an anchor for securing the passageway, wherein said passageway is completely outside the pylorus.

2. An apparatus according to claim 1, wherein the anchor is selected from the group consisting of magnets, clamps, clips, staples and adhesives.

3. An apparatus according to claim 1, wherein said valve is a one way valve.

4. An apparatus according to claim 1, wherein said valve is a flow restriction valve.

5. An apparatus according to claim 1, further comprising an injection port for inflating first or second inflatable chambers.

6. An apparatus according to claim 5, wherein the first and second inflatable chambers can be inflated with a liquid or a gas.

7. An apparatus according to claim 6, wherein the liquid is a compressible liquid.

8. A method of treating obesity comprising creating a fistula between a stomach and an intestine of a patient by positioning an apparatus of claim 1, wherein the inlet is positioned in the antrum of the stomach and the outlet is positioned in the duodenum, jejunum, small intestine, large intestine, or colon;

and inflating the first and second expandable chambers.